about
Association of the human papillomavirus type 11 E1 protein with histone H1Brd4-independent transcriptional repression function of the papillomavirus e2 proteinsDNA bending by an adenine-thymine tract and its role in gene regulationEvasion of host immune defenses by human papillomavirusAnalysis of the papillomavirus E2 and bromodomain protein Brd4 interaction using bimolecular fluorescence complementationPhosphorylation of HPV-16 E2 at serine 243 enables binding to Brd4 and mitotic chromosomesInteraction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral ReplicationA quasi-spontaneous amyloid route in a DNA binding gene regulatory domain: The papillomavirus HPV16 E2 protein.Novel human gammapapillomavirus species in a nasal swab.Recruitment of replication protein A by the papillomavirus E1 protein and modulation by single-stranded DNAIdentification of peptides that inhibit the DNA binding, trans-activator, and DNA replication functions of the human papillomavirus type 11 E2 protein.Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins.Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repressionPapillomavirus interaction with cellular chromatin.Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expressionViral DNA Replication Orientation and hnRNPs Regulate Transcription of the Human Papillomavirus 18 Late Promoter.The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domainsTransactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell linesCharacterization of the DNA-binding domain of the bovine papillomavirus replication initiator E1.Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivoMechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31.NCoR1 mediates papillomavirus E8;E2C transcriptional repressionDNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirusInteraction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin.Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.A point mutation in the DNA-binding domain of HPV-2 E2 protein increases its DNA-binding capacity and reverses its transcriptional regulatory activity on the viral early promoter.Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication.A transactivator function of cottontail rabbit papillomavirus e2 is essential for tumor induction in rabbits.Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.High efficiency, long-term clinical expression of cottontail rabbit papillomavirus (CRPV) DNA in rabbit skin following particle-mediated DNA transfer.During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.Evolutionary variation of papillomavirus E2 protein and E2 binding sites.Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.Induction of structural changes in the bovine papillomavirus type 1 origin of replication by the viral E1 and E2 proteinsThe bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric E1-replication origin complex.E1 protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication.Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes.
P2860
Q24316941-5640C432-696B-4800-A990-D281C94A03EEQ24671845-1E366BAB-2D32-45B7-BBDE-499E3500CA01Q27633005-A8F86731-875B-4DE3-9B1D-CF9312509019Q28076194-BF62EF18-888C-4156-BBEB-112FA0020A0FQ28534628-CCE7ABFD-7CFB-4A56-A8E9-38630A5A726BQ28544058-EB0A5BA1-B4FC-42A8-9C0D-8D72CC310519Q28551261-53881DE3-D194-40A1-8FC6-C76D5270E117Q30158017-FA52DF6A-AD68-49FE-9E31-770381448BE5Q30604659-0AD5D646-9007-4B0F-8DA9-66A3D3E4B6A0Q31038703-379778FA-0908-4FB5-BADF-731464F4FF86Q31047717-B8CEB2CC-1686-471F-B55D-2A503E8F53B4Q33292524-48917B3C-2A1D-40DF-BFE4-B26BF129C384Q33558774-F0D2DABC-B98B-4D23-9C8B-4023C7703C75Q33729502-84CA2074-2245-4CD1-9785-04D17C82ADB0Q33734803-4CDDCB8C-6787-44EC-AACE-346A9B6EFEA3Q33741262-60E8CA33-2A30-44A7-AF97-B41AE5CC4A9FQ33781905-9FE4FFC9-67E6-4A1F-8FE2-7F5DE8431DC1Q33782708-FE38FCC3-CAD2-4139-8569-40476C7D1C9AQ33782934-5F078A21-D2C4-47C0-8963-572E39F222CCQ33784825-144D30CC-539F-4BD2-BBDA-62A39E249CDFQ33785593-33040BB4-1C7A-41F8-B086-13FB32818EFFQ33802567-0F5E5493-0BAF-4942-A1F2-DBB6928D2EE0Q33803580-7271FD97-E319-4DA1-97A4-273D49786121Q33826645-683B0EAE-AF33-4AB0-A668-E2B2A114D1F1Q33853499-FE9A8C04-CE8C-45E5-8C9D-3074FDD1F87BQ33884073-B6DD43EC-1319-4D7F-BF8E-5A838E86395AQ33961239-F9195400-5F76-4AB1-98CE-819EDC57265DQ34158732-15D74A57-23CB-4241-88C0-E5DB6BF59E47Q34338679-94D1F11E-FDE5-4C03-9B58-EB2284F38ACAQ34354844-816E5D61-75AD-435C-8BFA-A35B7509D0B4Q34361895-83E89F4D-F34B-40FF-B8A1-C88037BB77B6Q34578434-29DA45F3-E1E4-4312-9D54-CDDB5AEBB914Q34602335-F4F15BAE-EDF2-423B-A6CB-DC143220E3C9Q35011943-728E1811-BA75-4B8D-9BF6-F1D9AF4B4BB7Q35181734-0200EDBB-4E28-4396-A412-53379D2882DAQ35589596-990B5B2D-1D13-4919-A0D1-E5CA8202F3C3Q35750818-29942453-5DE4-4BB7-9D24-E0577A05CB82Q35753237-598F6979-05D5-4B14-AF99-4CA8EC824B07Q35800028-390AFC3D-F028-4E0C-838B-1933890BEC36Q35829913-A6748EB0-6F59-403A-BF4D-229C9EB757C3
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
The papillomavirus E2 regulatory proteins.
@ast
The papillomavirus E2 regulatory proteins.
@en
type
label
The papillomavirus E2 regulatory proteins.
@ast
The papillomavirus E2 regulatory proteins.
@en
prefLabel
The papillomavirus E2 regulatory proteins.
@ast
The papillomavirus E2 regulatory proteins.
@en
P2093
P1476
The papillomavirus E2 regulatory proteins
@en
P2093
McBride AA
Romanczuk H
P304
18411-18414
P407
P577
1991-10-01T00:00:00Z